Investment House LLC Bristol Myers Squibb CO Transaction History

Investment House LLC

  • $1.75 Billion
  • Q2 2024

A detailed history of Investment House LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investment House LLC holds 45,395 shares of BMY stock, worth $2.42 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
45,395
Previous 32,570 39.38%
Holding current value
$2.42 Million
Previous $1.77 Million 6.74%
% of portfolio
0.11%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024
BUY
$40.25 - $52.99 $516,206 - $679,596
12,825 Added 39.38%
45,395 $1.89 Million
Q1 2024

May 02, 2024
BUY
$47.98 - $54.4 $603,348 - $684,080
12,575 Added 62.89%
32,570 $1.77 Million
Q4 2023

Feb 05, 2024
SELL
$48.48 - $57.85 $236,000 - $281,613
-4,868 Reduced 19.58%
19,995 $1.03 Million
Q3 2023

Nov 09, 2023
SELL
$57.89 - $64.73 $580,463 - $649,047
-10,027 Reduced 28.74%
24,863 $1.44 Million
Q2 2023

Aug 08, 2023
SELL
$63.71 - $70.74 $1.59 Million - $1.77 Million
-25,000 Reduced 41.74%
34,890 $2.23 Million
Q1 2023

May 09, 2023
SELL
$65.71 - $74.53 $38,440 - $43,600
-585 Reduced 0.97%
59,890 $4.15 Million
Q4 2022

Feb 07, 2023
SELL
$68.48 - $81.09 $293,779 - $347,876
-4,290 Reduced 6.62%
60,475 $4.35 Million
Q3 2022

Oct 31, 2022
BUY
$0.13 - $76.84 $333 - $196,940
2,563 Added 4.12%
64,765 $4.6 Million
Q2 2022

Aug 09, 2022
BUY
$72.62 - $79.98 $1.11 Million - $1.22 Million
15,275 Added 32.55%
62,202 $4.79 Million
Q1 2022

Apr 14, 2022
SELL
$61.48 - $73.72 $543,421 - $651,611
-8,839 Reduced 15.85%
46,927 $3.43 Million
Q4 2021

Feb 09, 2022
SELL
$53.63 - $62.52 $519,138 - $605,193
-9,680 Reduced 14.79%
55,766 $3.48 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $42,188 - $49,418
713 Added 1.1%
65,446 $3.87 Million
Q2 2021

Jul 20, 2021
BUY
$61.91 - $67.42 $321,622 - $350,246
5,195 Added 8.73%
64,733 $4.33 Million
Q1 2021

May 06, 2021
BUY
$59.34 - $66.74 $215,463 - $242,332
3,631 Added 6.49%
59,538 $3.76 Million
Q4 2020

Jan 13, 2021
BUY
$57.74 - $65.43 $493,099 - $558,772
8,540 Added 18.03%
55,907 $3.47 Million
Q3 2020

Nov 06, 2020
BUY
$57.43 - $63.64 $101,076 - $112,006
1,760 Added 3.86%
47,367 $2.86 Million
Q2 2020

Jul 13, 2020
BUY
$54.82 - $64.09 $135,515 - $158,430
2,472 Added 5.73%
45,607 $2.68 Million
Q1 2020

Apr 08, 2020
BUY
$46.4 - $67.43 $265,732 - $386,171
5,727 Added 15.31%
43,135 $2.4 Million
Q4 2019

Feb 05, 2020
BUY
$49.21 - $64.19 $817,574 - $1.07 Million
16,614 Added 79.9%
37,408 $2.4 Million
Q3 2019

Nov 12, 2019
SELL
$42.77 - $50.71 $87,678 - $103,955
-2,050 Reduced 8.97%
20,794 $1.05 Million
Q2 2019

Aug 05, 2019
SELL
$44.62 - $49.34 $328,403 - $363,142
-7,360 Reduced 24.37%
22,844 $1.04 Million
Q1 2019

May 03, 2019
SELL
$45.12 - $53.8 $271,848 - $324,145
-6,025 Reduced 16.63%
30,204 $1.44 Million
Q4 2018

Feb 06, 2019
SELL
$48.76 - $63.23 $159,689 - $207,078
-3,275 Reduced 8.29%
36,229 $1.88 Million
Q3 2018

Oct 09, 2018
SELL
$55.19 - $62.25 $11,038 - $12,450
-200 Reduced 0.5%
39,504 $2.45 Million
Q2 2018

Jul 10, 2018
BUY
$50.53 - $62.98 $5,053 - $6,298
100 Added 0.25%
39,704 $2.2 Million
Q1 2018

May 08, 2018
SELL
$59.92 - $68.98 $29,960 - $34,490
-500 Reduced 1.25%
39,604 $2.51 Million
Q4 2017

Jan 31, 2018
SELL
$59.94 - $65.35 $55,444 - $60,448
-925 Reduced 2.25%
40,104 $2.46 Million
Q3 2017

Oct 30, 2017
BUY
$55.23 - $63.74 $2.27 Million - $2.62 Million
41,029
41,029 $2.62 Million

Others Institutions Holding BMY

# of Institutions
2,425
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email